Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
refills authorization of authorization of dispensing of prescriptions long-term care facilities multiple refills written on same day schedule III, IV, and V substances
registration, CSA applications for denial, revocation, or suspension dispensing distribution exemptions manufacturing modification, transfer, or termination research with controlled substance separate registrations
registration number, DEA
regulation approaches for outcomes of managed care plan formularies of prescription drug samples reasons for State Regulation of Third-Party Plans
reimbursement for drugs
reimportation of drugs
See risk evaluation and mitigation strategies (REMS) Bibliography Drug Price Competition and Patent Term Restoration Act of 1984 Food and Drug Administration Amendments Act of 2007 Historical Overview of the Federal Food, Drug, and Cosmetic Act New Drug Approval Preface Prescription Drug Labeling Information for the Patient Purpose of a Controlled Substance Prescription See risk evaluation and mitigation strategies (REMS) The Road to an Approved New Drug Application Useful Written Patient Information and Medication Guides
Renacidin
repackaging drugs adulteration regulations Food, Drug, and Cosmetic Act offenses manufacturing, defined
reregistration, applications for
research, with controlled substance
Res ipsa loquitur
Restatement (Second) of Torts, Section 402A
retail community pharmacy
retail pharmacy
retrospective review, drug use review
reverse payment agreements
Riegel v. Medtronic, Inc. (2008)
Riff v. Morgan Pharmacy (1986)
right-to-try laws
risk evaluation and mitigation strategies (REMS) Drug Information Website for Consumers and Health Professionals: Drugs@FDA FDA Safety and Innovation Act of 2012 The Road to an Approved New Drug Application
risk management continuous quality improvement programs Continuous Quality Improvement Programs as Risk Management institutional controls malpractice insurance malpractice overview overview pharmacist as risk manager problems and pitfalls of rules for strategies
Rite Aid
Rite Aid Corp. v. Board of Pharmacy (1976)
Rite Aid of New Jersey, Inc. v. Board of Pharmacy (1973)
robbery
Robinson-Patman Act (1936) aftermath of portland decision brand-name prescription drugs antitrust litigation competing buyers and injury to competition meeting competition defense Nonprofit Institutions Act The Robinson-Patman Act “own use” doctrine
rogue pharmacies
(1984) Regulation of Managed Care Plan Formularies/Drug Pricing The Sherman Antitrust Act
See Rule Review Commission (RRC) Law Made by Administrative Agencies See Rule Review Commission (RRC)